Sean Marvil, MD
Orthopaedic Surgery · Taos, NMNPI 1891924668
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Arthrex at 40.7% of the total. Reporting peaked in 2019 at $2,639 and has fallen 80.7% since, to $509 in 2025.
Across 92 payments — averaging $93.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Medacta USA, Inc.$1K
- Smith+Nephew$870
- Stryker$846
- FX Shoulder Solutions, Inc$669
- Gemini Mountain Medical, LLC$460
- plus $928 from 8 others
What the payments were for
- Travel & lodging$1,31915%
- Food & beverage$4,59154%
- Education$2,67031%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 20 | $3,488 |
| Medacta USA, Inc. | 25 | $1,320 |
| Smith+Nephew | 9 | $870 |
| Stryker | 12 | $846 |
| FX Shoulder Solutions, Inc | 5 | $669 |
| Gemini Mountain Medical, LLC | 6 | $460 |
| Zimmer Biomet | 4 | $331 |
| Alliance Medical | 4 | $202 |
| Johnson & Johnson | 2 | $150 |
| BREG, Inc | 1 | $135 |
| Pacira Pharmaceuticals Incorporated | 1 | $40 |
| DJO, LLC | 1 | $36 |
| Pacira Therapeutics, Inc. | 1 | $17 |
| Vericel Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$1,051
- AMISTEM$393
- INSPACE$148
- ROSA-Knee$145
- Breg VPULSE, PlasmaFlow, PolarCareWave$135
- B1132N2AI300100$135
- GMK SPHERE$127
- TFN ADVANCED$125
- AEQUALIS ASCEND FLEX$116
- ADAPT$114
- VISIONAIRE$107
- NANO TACT FLEX$105
How this compares
$8,579 in reported general payments places this provider in the 70th percentile of 107 orthopaedic surgery providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clindamycin Phosphate | 69 | $1,365 |
| Celecoxib | 53 | $1,041 |
| Mupirocin | 72 | $596 |
| Amoxicillin | 12 | $30 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Taos
- Dan GuttmanTaos$530K
- Luciano RamiresTaos$24K
- Matthew SpittlerTaos$10K
- Deana MercerAlbuquerque$901K
- David ChafeyAlbuquerque$108K
- Heather MenzerAlbuquerque$61K
- Ernesto Otero LopezAlbuquerque$50K
- Rick GehlertAlbuquerque$46K
- Jeffrey BeckenbaughAlbuquerque$46K
- Gustavo BarrazuetaCarlsbad$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.